123 related articles for article (PubMed ID: 33796946)
1. The value of asphericity derived from T1-weighted MR in differentiating intraparenchymal ring-enhancing lesions-comparison of glioblastomas and brain abscesses.
Zeng T; Xu Z; Yan J
Neurol Sci; 2021 Dec; 42(12):5171-5175. PubMed ID: 33796946
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
Bauer AH; Erly W; Moser FG; Maya M; Nael K
Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
[TBL] [Abstract][Full Text] [Related]
7. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
8. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
11. Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.
Wen JB; Huang WY; Xu WX; Wu G; Geng DY; Yin B
J Comput Assist Tomogr; 2017; 41(6):904-909. PubMed ID: 28708728
[TBL] [Abstract][Full Text] [Related]
12. Histogram analysis based on diffusion kurtosis imaging: Differentiating glioblastoma multiforme from single brain metastasis and comparing the diagnostic performance of two region of interest placements.
Gao E; Gao A; Kit Kung W; Shi L; Bai J; Zhao G; Cheng J
Eur J Radiol; 2022 Feb; 147():110104. PubMed ID: 34972059
[TBL] [Abstract][Full Text] [Related]
13. Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI.
Chun CW; Jung JY; Baik JS; Jee WH; Kim SK; Shin SH
J Magn Reson Imaging; 2018 Jan; 47(1):60-68. PubMed ID: 28432835
[TBL] [Abstract][Full Text] [Related]
14. True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.
Song YS; Choi SH; Park CK; Yi KS; Lee WJ; Yun TJ; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Jahng GH; Chang KH
Korean J Radiol; 2013; 14(4):662-72. PubMed ID: 23901325
[TBL] [Abstract][Full Text] [Related]
15.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy.
Nam JG; Kang KM; Choi SH; Lim WH; Yoo RE; Kim JH; Yun TJ; Sohn CH
AJNR Am J Neuroradiol; 2017 Dec; 38(12):2243-2250. PubMed ID: 29074633
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI.
Chang SC; Lai PH; Chen WL; Weng HH; Ho JT; Wang JS; Chang CY; Pan HB; Yang CF
Clin Imaging; 2002; 26(4):227-36. PubMed ID: 12140151
[TBL] [Abstract][Full Text] [Related]
20. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
